WEBSITE BSE:506285 NSE : BAYER CROP 13 May, 15:55
Market Cap ₹23451 Cr.
Stock P/E 29.2
P/B 7.3
Current Price ₹5218
Book Value ₹ 717.5
Face Value 10
52W High ₹6202
Dividend Yield 2.49%
52W Low ₹ 4090
Bayer CropScience Ltd is engaged inside the production of insecticides, rodenticides, fungicides and herbicides. The Company operates thru Agri Care section. The Company gives crop solutions for various crops, such as millet, mustard, pulses, cotton, fruits, rice, soybeans, sugar cane, vegetables and wheat. The Company offers diverse pest control solutions, along with Professional Pest Management for household / structural pests and Vector Management for pests that pose a danger to public health. The Company offers numerous manufacturers, including Folicur, Melody Duo, Nativo, Aliette, Antracol, beneath the fungicides category; Laudis, Lucifer, Raft, Ricestar, Adora, Adue, Atlantis, Basta, and Topstar under the herbicides class; Decis 100, Fame, Flotis, Jump, Admire, Alanto, Confidor, Larvin, Oberon and Spintor under the pesticides class; Gaucho, Raxil Easy, Monceren, Raxil below the SeedGrowth class, and Ethrel and Planofix beneath the others category.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1365 | 990 | 963 | 1667 | 1452 | 1038 | 983 | 1740 | 1617 | 955 |
Other Income | 14 | 10 | 16 | 14 | 14 | 15 | 21 | 21 | 16 | 15 |
Total Income | 1379 | 1000 | 979 | 1682 | 1466 | 1053 | 1003 | 1760 | 1633 | 970 |
Total Expenditure | 1143 | 924 | 763 | 1272 | 1214 | 953 | 777 | 1315 | 1312 | 827 |
Operating Profit | 236 | 76 | 216 | 409 | 252 | 101 | 227 | 445 | 321 | 143 |
Interest | 2 | 3 | 6 | 4 | 8 | 3 | 7 | 8 | 4 | 3 |
Depreciation | 14 | 14 | 21 | 23 | 15 | 14 | 27 | 31 | 12 | 15 |
Exceptional Income / Expenses | 0 | 59 | 0 | 0 | 0 | 101 | 3 | 0 | 0 | 0 |
Profit Before Tax | 220 | 118 | 190 | 382 | 229 | 184 | 195 | 406 | 306 | 124 |
Provision for Tax | 65 | 33 | 37 | 80 | 66 | 49 | 37 | 78 | 83 | 31 |
Profit After Tax | 154 | 85 | 153 | 303 | 163 | 135 | 159 | 329 | 223 | 93 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 154 | 85 | 153 | 303 | 163 | 135 | 159 | 329 | 223 | 93 |
Adjusted Earnings Per Share | 34.3 | 18.9 | 34 | 67.4 | 36.2 | 30 | 35.3 | 73.2 | 49.6 | 20.7 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2725 | 3245 | 3723 | 2769 | 2803 | 2710 | 3167 | 3609 | 4261 | 4734 | 5140 | 5295 |
Other Income | 69 | 91 | 91 | 82 | 72 | 39 | 53 | 67 | 66 | 60 | 73 | 73 |
Total Income | 2794 | 3336 | 3814 | 2851 | 2874 | 2749 | 3221 | 3676 | 4327 | 4794 | 5213 | 5366 |
Total Expenditure | 2365 | 2840 | 3211 | 2335 | 2391 | 2301 | 2687 | 2884 | 3452 | 3929 | 4225 | 4231 |
Operating Profit | 429 | 496 | 603 | 516 | 484 | 448 | 534 | 792 | 876 | 866 | 988 | 1136 |
Interest | 4 | 5 | 5 | 10 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 22 |
Depreciation | 37 | 50 | 25 | 25 | 29 | 33 | 44 | 65 | 74 | 65 | 80 | 85 |
Exceptional Income / Expenses | 1175 | 0 | 0 | 0 | 0 | 0 | 0 | -130 | 5 | 59 | 104 | 3 |
Profit Before Tax | 1563 | 441 | 574 | 482 | 448 | 404 | 480 | 583 | 795 | 847 | 990 | 1031 |
Provision for Tax | 402 | 151 | 191 | 167 | 157 | 104 | 143 | 109 | 301 | 202 | 232 | 229 |
Profit After Tax | 1162 | 290 | 383 | 315 | 291 | 300 | 337 | 475 | 493 | 645 | 758 | 804 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 1162 | 290 | 383 | 315 | 291 | 300 | 337 | 475 | 493 | 645 | 758 | 804 |
Adjusted Earnings Per Share | 294.1 | 79.1 | 104.6 | 89 | 82.2 | 87.5 | 98.3 | 105.7 | 109.8 | 143.7 | 168.9 | 178.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 9% | 13% | 14% | 7% |
Operating Profit CAGR | 14% | 8% | 17% | 9% |
PAT CAGR | 18% | 17% | 20% | -4% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 27% | -1% | 5% | 13% |
ROE Average | 29% | 25% | 22% | 25% |
ROCE Average | 39% | 35% | 31% | 36% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 1931 | 1742 | 2033 | 1839 | 2057 | 1778 | 2239 | 2573 | 2550 | 2524 | 2712 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 588 | 53 | 1155 | 1359 | 1539 | 1502 | 1614 | 1590 | 1783 | 2365 | 2792 |
Total Current Liabilities | 821 | 1667 | 856 | 538 | 829 | 950 | 1684 | 1765 | 2273 | 2073 | 2011 |
Total Liabilities | 3340 | 3462 | 4044 | 3737 | 4425 | 4230 | 5537 | 5928 | 6607 | 6962 | 7516 |
Fixed Assets | 219 | 228 | 322 | 290 | 311 | 304 | 409 | 438 | 395 | 441 | 437 |
Other Non-Current Assets | 745 | 309 | 1175 | 1409 | 1594 | 1562 | 1852 | 1850 | 1965 | 2531 | 2949 |
Total Current Assets | 2377 | 2925 | 2548 | 2037 | 2520 | 2364 | 3271 | 3640 | 4247 | 3989 | 4130 |
Total Assets | 3340 | 3462 | 4044 | 3737 | 4425 | 4230 | 5537 | 5928 | 6607 | 6962 | 7516 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 429 | 973 | 486 | 1130 | 762 | 838 | 417 | 578 | 1067 | 1205 | 781 |
Cash Flow from Operating Activities | 138 | 282 | 200 | 207 | 157 | 121 | 433 | 666 | 687 | 216 | 609 |
Cash Flow from Investing Activities | 427 | -290 | 485 | 16 | -8 | 38 | -415 | -29 | 7 | 64 | 83 |
Cash Flow from Financing Activities | -21 | -480 | -42 | -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 |
Net Cash Inflow / Outflow | 544 | -488 | 644 | -367 | 76 | -421 | -140 | 489 | 138 | -424 | 79 |
Closing Cash & Cash Equivalent | 973 | 486 | 1130 | 762 | 838 | 417 | 578 | 1067 | 1205 | 781 | 860 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 294.1 | 79.1 | 104.64 | 89.01 | 82.2 | 87.49 | 98.28 | 105.68 | 109.82 | 143.72 | 168.86 |
CEPS(Rs) | 303.37 | 92.81 | 111.56 | 95.99 | 90.37 | 97.14 | 111.05 | 120.22 | 126.19 | 158.08 | 186.57 |
DPS(Rs) | 5 | 5.5 | 21 | 17 | 17 | 18 | 18 | 25 | 115 | 150 | 130 |
Book NAV/Share(Rs) | 488.94 | 476.04 | 555.44 | 519.6 | 580.99 | 518.45 | 649.8 | 572.94 | 568 | 562.2 | 604.03 |
Core EBITDA Margin(%) | 12.68 | 11.91 | 13.13 | 15.02 | 13.98 | 14.88 | 13.7 | 17.66 | 16.75 | 14.78 | 15.51 |
EBIT Margin(%) | 55.19 | 13.11 | 14.81 | 17.01 | 15.43 | 15.1 | 13.97 | 14.53 | 16.7 | 15.77 | 17.16 |
Pre Tax Margin(%) | 55.06 | 12.97 | 14.69 | 16.67 | 15.19 | 14.69 | 13.68 | 14.19 | 16.44 | 15.53 | 16.78 |
PAT Margin (%) | 40.92 | 8.52 | 9.81 | 10.91 | 9.87 | 10.92 | 9.6 | 11.55 | 10.2 | 11.84 | 12.85 |
Cash Profit Margin (%) | 42.21 | 9.99 | 10.46 | 11.76 | 10.85 | 12.12 | 10.85 | 13.14 | 11.72 | 13.02 | 14.2 |
ROA(%) | 37.21 | 8.51 | 10.21 | 8.1 | 7.13 | 6.93 | 6.9 | 8.28 | 7.87 | 9.51 | 10.47 |
ROE(%) | 85.29 | 15.76 | 20.29 | 16.27 | 14.94 | 15.65 | 16.83 | 19.77 | 19.25 | 25.43 | 28.96 |
ROCE(%) | 115.04 | 24.26 | 30.63 | 25.39 | 23.35 | 21.65 | 24.41 | 24.8 | 31.5 | 33.88 | 38.67 |
Receivable days | 37.19 | 39.32 | 45.87 | 61.65 | 59.51 | 80.68 | 70.58 | 62.93 | 55.61 | 58.91 | 61.25 |
Inventory Days | 64.25 | 56.35 | 52.1 | 77.64 | 88.68 | 100.11 | 98.63 | 94.2 | 86.4 | 94.98 | 102.67 |
Payable days | 48.6 | 42.92 | 42.41 | 60.13 | 57.04 | 67.53 | 107.39 | 112.12 | 102.62 | 118.74 | 114.74 |
PER(x) | 4.1 | 19.05 | 31.78 | 42.34 | 46.15 | 48.04 | 44.61 | 32.73 | 48.31 | 34.67 | 23.97 |
Price/Book(x) | 2.46 | 3.17 | 5.99 | 7.25 | 6.53 | 8.11 | 6.75 | 6.04 | 9.34 | 8.86 | 6.7 |
Dividend Yield(%) | 0.41 | 0.36 | 0.63 | 0.45 | 0.45 | 0.43 | 0.41 | 0.72 | 2.17 | 3.01 | 3.21 |
EV/Net Sales(x) | 1.4 | 1.55 | 2.97 | 4.54 | 4.49 | 5.17 | 4.56 | 4.01 | 5.31 | 4.56 | 3.37 |
EV/Core EBITDA(x) | 8.92 | 10.15 | 18.3 | 24.36 | 26.03 | 31.23 | 27.06 | 18.25 | 25.83 | 24.93 | 17.52 |
Net Sales Growth(%) | 19.94 | 19.08 | 14.73 | -25.63 | 1.22 | -3.31 | 16.88 | 13.96 | 18.06 | 11.1 | 8.56 |
EBIT Growth(%) | 660.26 | -71.56 | 29.74 | -14.96 | -7.49 | -8.73 | 18.14 | 21.72 | 35.22 | 6.52 | 17.76 |
PAT Growth(%) | 735.76 | -75.08 | 32.3 | -17.73 | -7.65 | 3.13 | 12.33 | 40.76 | 3.92 | 30.87 | 17.5 |
EPS Growth(%) | 735.75 | -73.11 | 32.3 | -14.94 | -7.65 | 6.43 | 12.33 | 7.53 | 3.92 | 30.87 | 17.5 |
Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 2.9 | 1.75 | 2.98 | 3.79 | 3.04 | 2.49 | 1.94 | 2.06 | 1.87 | 1.92 | 2.05 |
Quick Ratio(x) | 2.29 | 1.43 | 2.32 | 2.55 | 2.11 | 1.71 | 1.26 | 1.52 | 1.29 | 1.19 | 1.15 |
Interest Cover(x) | 423.49 | 92.83 | 125.67 | 49.16 | 65.91 | 36.73 | 47.15 | 43.25 | 64.06 | 66.64 | 45.4 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 |
FII | 2.99 | 2.9 | 2.95 | 3.1 | 3.19 | 3.18 | 3.18 | 3.3 | 3.54 | 3.62 |
DII | 12.53 | 12.9 | 13.1 | 12.76 | 12.78 | 12.75 | 13.06 | 13.23 | 12.7 | 12.8 |
Public | 13.05 | 12.77 | 12.51 | 12.71 | 12.61 | 12.64 | 12.33 | 12.04 | 12.33 | 12.15 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 |
FII | 0.13 | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 | 0.14 | 0.15 | 0.16 | 0.16 |
DII | 0.56 | 0.58 | 0.59 | 0.57 | 0.57 | 0.57 | 0.59 | 0.59 | 0.57 | 0.58 |
Public | 0.59 | 0.57 | 0.56 | 0.57 | 0.57 | 0.57 | 0.55 | 0.54 | 0.55 | 0.55 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About